The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease
Abstract
Excitatory neurotransmitter dysfunction has been discussed to be involved in the pathophysiology of Alzheimer's disease (AD). In the current study we investigated gene and protein expression patterns of glutamatergic receptors and transporters in brains of AD patients in various stages of disease using gene chip arrays, real time PCR and immunohistochemistry. We found marked impairment in the expression of excitatory amino acid transporters (EAAT1 and EAAT 2) at both gene and protein levels in hippocampus and gyrus frontalis medialis of AD patients, already in early clinical stages of disease. The loss of EAAT immunoreactivity was particularly obvious in the vicinity of amyloid plaques. In contrast, EAAT expression was up-regulated in the cerebellum of these patients. Furthermore, a significant up-regulation of the glutamatergic kainate (GRIK4) receptor observed by gene arrays was confirmed by quantitative RT-PCR in late stages in the hippocampus of AD patients. Moreover, there were down-regulations of other glutamatergic receptors such as NMDA (GRINL1A) and AMPA (GRIA4) receptors. Our data show marked changes in the functional elements of the glutamatergic synapses such as glutamatergic receptors and transporters and indicate impaired glutamate clearing rendering neurons susceptible to excess extracellular glutamate and support further the involvement of excitotoxic mechanisms in the pathogenesis of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss or dysfunction of SLC1A2 has been implicated in multiple neurodegenerative and neuropsychiatric disorders, including AD where it is closely associated with cognitive decline [126–131].”
From Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease (2026) · cites this paper as [128]
In the citing paper
“Downregulation of the GluN1 subunit is observed in AD patient brain at different stages of neurodegenerative onset [60].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [60]
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
High density synthetic oligonucleotide arrays
Lipshutz, R. J., Fodor, S. P. A., Gingeras, T., & Lockhart, D. J. (1999) · Nature Genetics · doi:10.1038/4447 · Cited by 2,204
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Gene-expression profile of the ageing brain in mice
Lee, C.-K., Weindruch, R., & Prolla, T. A. (2000) · Nature Genetics · doi:10.1038/77046 · Cited by 1,055
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond
Lipton, S. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1958 · Cited by 909
Lee, M. T., Kuo, F. C., Whitmore, G. A., & Sklar, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.9834 · Cited by 861
Kainic Acid-Mediated Excitotoxicity as a Model for Neurodegeneration
Wang, Q., Yu, S. O., Simonyi, Á., Sun, G. Y., & Sun, A. Y. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:003 · Cited by 365
Grünblatt, E., Mandel, S. A., Jacob‐Hirsch, J., Zeligson, S., Amariglo, N., Rechavi, G., Li, J., Ravid, R., Roggendorf, W., Riederer, P. F., et al. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0212-1 · Cited by 355
Self-citationPattern of brain destruction in Parkinson's and Alzheimer's diseases
Braak, H., Braak, E., Yilmazer‐Hanke, D., de Vos, R. A. I., Jansen, E. N. H., & Böhl, J. (1996) · Journal of Neural Transmission · doi:10.1007/bf01276421 · Cited by 326
Computational methods for theidentification of differential and coordinated gene expression
Claverie, J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.10.1821 · Cited by 287
Alzheimer’s disease-related alterations in synaptic density: neocortex and hippocampus.
Scheff, S. W., & Price, D. A. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s312 · Cited by 284
Floden, A. M., Li, S., & Combs, C. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4998-04.2005 · Cited by 254
NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation
Amadoro, G., Ciotti, M. T., Costanzi, M., Cestari, V., Calissano, P., & Canu, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511065103 · Cited by 243
Vandesompele, J., Paepe, A. D., & Speleman, F. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5564 · Cited by 231
RNA Amplification Results in Reproducible Microarray Data with Slight Ratio Bias
Puskás, L. G., Zvara, Á., Hackler, L., & Hummelen, P. V. (2002) · BioTechniques · doi:10.2144/02326mt04 · Cited by 226
NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production
Lesné, S., Ali, C., Gabriel, C., Croci, N., MacKenzie, E. T., Glabe, C. G., Plotkine, M., Marchand‐Leroux, C., Vivien, D., & Buisson, A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0849-05.2005 · Cited by 211
Moechars, D., Lorent, K., De Strooper, B., Dewachter, I., & Van Leuven, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00468.x · Cited by 201
Lukiw, W. J., & Bazan, N. G. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980901)53:5 · Cited by 182
Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia
Miwa, T., Furukawa, S., Nakajima, K., Furukawa, Y., & Kohsaka, S. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19971215)50:6 · Cited by 181
EGR1 Target Genes in Prostate Carcinoma Cells Identified by Microarray Analysis
Svaren, J. P., Ehrig, T., Abdulkadir, S. A., Ehrengruber, M. U., Watson, M. A., & Milbrandt, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005220200 · Cited by 169
Alzheimer's disease: amyloid plaques in the cerebellum
Braak, H., Braak, E., Böhl, J., & Lang, W. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90197-4 · Cited by 157
Quantification of splice variants using real-time PCR
Vandenbroucke, I. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.13.e68 · Cited by 150
Blanchard, B. J., Chen, A., Rozeboom, L. M., Stafford, K. A., Weigele, P., & Ingram, V. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405941101 · Cited by 149
Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice
Masliah, E., Alford, M. F., Mallory, M. E., Rockenstein, E. M., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7386 · Cited by 148
Differential Gene Expression Patterns Revealed by Oligonucleotide Versus Long cDNA Arrays
Li, J. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.2.383 · Cited by 121
Differential expression of N‐methyl‐d‐aspartate receptor NR2 isoforms in Alzheimer's disease
Hynd, M., Scott, H., & Dodd, P. R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02548.x · Cited by 118
Benoît, M., Koulibaly, P. M., Migneco, O., Darcourt, J., Pringuey, D., & Robert, P. H. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00003-3 · Cited by 118
Free radicals in Parkinson's disease
Koutsilieri, E., Scheller, C., Grünblatt, E., Keinosuke, N. A. R. A., Li, J., & Riederer, P. F. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1201-7 · Cited by 117
Self-citationA comparison of statistical methods for analysis of high density oligonucleotide array data
Rajagopalan, D. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg202 · Cited by 112
Groot, C. J. A. D., Langeveld, C. H., Jongenelen, C. A. M., Montagne, L., van der Valk, P., & Dijkstra, C. D. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970801)49:3 · Cited by 97
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease
Zoia, C., Cogliati, T., Tagliabue, E., Cavaletti, G., Sala, G., Galimberti, G., Rivolta, I., Rossi, V., Frattola, L., & Ferrarese, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00085-x · Cited by 85
Alzheimer's disease: neuropathological correlates of cognitive and motor disorders
Mölsä, P. K., Säkö, E., Paljärvi, L., Rinne, J. O., & Rinne, U. K. (1987) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1987.tb05465.x · Cited by 68
Gene expression profile in streptozotocin rat model for sporadic Alzheimer?s disease
Grünblatt, E., Hoyer, S., & Riederer, P. F. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0030-x · Cited by 63
Self-citationFrom benefit to damage. Glutamate and advanced glycation end products in Alzheimer brain
Riederer, P. F., & Hoyer, S. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0591-6 · Cited by 56
Self-citationHippocampal sclerosis in Alzheimer disease and other dementias
Attems, J., & Jellinger, K. A. (2006) · Neurology · doi:10.1212/01.wnl.0000200959.50898.26 · Cited by 54
Marenco, S., & Weinberger, D. R. (2006) · CNS Drugs · doi:10.2165/00023210-200620030-00001 · Cited by 45
Liu, M., Sun, A., Shin, E., Liu, X., Kim, S. I., Runyons, C. R., Markesbery, W. R., Kim, H., & Bing, G. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04724.x · Cited by 45
Glutamate receptors modulate oxidative stress in neuronal cells. A mini-review
Болдырев, А. А., Bulygina, E. R., & Makhro, A. (2004) · Neurotoxicity Research · doi:10.1007/bf03033454 · Cited by 44
Oxidative stress related markers in the “VITA” and the centenarian projects
Grünblatt, E., Schlosser, R. J., Fischer, P. A., Fischer, M. O., Li, J., Koutsilieri, E., Wichart, I., Sterba, N., Rujescu, D., Møller, H. J., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.001 · Cited by 32
Self-citationUgozzoli, L. A., Chinn, D., & Hamby, K. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00016-7 · Cited by 21
Cited by
Sorted by citations
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Tu, S., Okamoto, S., Lipton, S. A., & Xu, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-48 · Cited by 613
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
Danysz, W., & Parsons, C. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02057.x · Cited by 500
Metadata
- Authors
- Jacob, C. P., Koutsilieri, E., Bartl, J., Neuen-Jacob, E., Arzberger, T., Zander, N., Ravid, R., Roggendorf, W., Riederer, P., & Grünblatt, E.
- Affiliations
- University of Würzburg (DE)
- Heinrich Heine University Düsseldorf (DE)
- Netherlands Brain Bank (NL)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2007-03-01
- Volume
- 11
- Issue
- 1
- Pages
- 97-116
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W118386170
- Cited by
- 317
- References
- 40
- Citations by year
- 2026: 11 · 2025: 31 · 2024: 14 · 2023: 19 · 2022: 29 · 2021: 23 · 2020: 26 · 2019: 18 · 2018: 19 · 2017: 14 · 2016: 14 · 2015: 17 · 2014: 11 · 2013: 11 · 2012: 8
- FWCI
- 8.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Female, Gene Expression Regulation, Humans, Male, Middle Aged, Reference Values, Receptors, Glutamate, Glutamic Acid, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Glutamate Plasma Membrane Transport Proteins, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review